Olympus Gets AUA Nod for Enlarged Prostate Procedure

The iTind procedure is intended for the treatment of symptoms due to urinary outflow obstruction.

Olympus Corporation

Olympus announced today that its iTind procedure is now included in the American Urological Association (AUA) clinical practice guideline for management of lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), also known as enlarged prostate. The iTind procedure is reflected in the new procedure category, Temporary Implanted Prostatic Devices (TIPD). The addition of the TIPD category is based on expert opinion reflecting peer-reviewed treatment recommendations and research updates.

The minimally invasive iTind procedure involves the placement of a temporarily implanted nitinol device that reshapes the prostatic urethra without burning or cutting out the prostate. The device remains in place for five to seven days while the patient is at home. Clinical data show that, upon removal, patients experience rapid and effective relief of their symptoms. The iTind procedure is an effective alternative to pharmaceutical therapy, as well as an alternative to surgeries and permanent implants, and is proven to relieve symptoms without affecting sexual and ejaculatory function or urinary continence.iii

"We are very pleased with the AUA's decision to update the clinical treatment guideline — a great close to September's National Prostate Health Month. As a result of this guidance, more physicians will be aware of the novel iTind procedure for the minimally invasive surgical treatment of LUTS secondary to BPH," said Harmeet Chhabra, Global Director for Health Economics and Market Access at Olympus Corporation. "This guidance reflects compelling clinical evidence and positive clinical experience with the iTind procedure."

BPH is a common health problem for men as they age, affecting approximately 50% of men between the ages of 51 and 60 and up to 90% of men over the age of 80. Symptoms of BPH include frequent urination with a sense of urgency and a weak urinary stream, and excessive urination at night.v Suffered over time, these symptoms can have a detrimental effect on quality of life for men and their families.vi

The iTind procedure is intended for the treatment of symptoms due to urinary outflow obstruction secondary to BPH in men aged 50 and above. Patients should consult their doctor to see if the iTind procedure is right for them. As with any medical procedure, implantation of the iTind device comes with the possibility of side effects, including pelvic discomfort, blood in urine, and/or painful or urgent urination. In rare cases, the iTind device may cause urinary tract infection or a sudden difficulty to urinate.

More in Surgical